ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 42 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 14, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	14,688	$52.47	$770,633.23	-0.5%	-51.2%	-59.9%
Feb 14, 2022	Voliotis Dimitris79	SVP, Clinical Development	Sell	601	$50.23	$30,187.75	-1.8%	-51.2%	-59.9%
Feb 14, 2022	Pinto Alexis	Chief Legal Officer	Sell	691	$50.23	$34,708.35	-1.5%	-51.2%	-59.9%
Feb 14, 2022	Sun Anthony Y81	President &CEO	Sell	4,733	$50.23	$237,733.23	-0.2%	-51.2%	-59.9%
Feb 7, 2022	Gallagher Cam81	Director	Sell	10,000	$53.45	$534,473.92	-0.8%	-63.9%	-60.6%
Feb 2, 2022	Sun Anthony Y81	President &CEO	Sell	20,942	$57.77	$1,209,891.86	-0.3%	-54.1%	-57.7%
Jan 20, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	10,000	$59.99	$599,911.95	-1.8%	-58.1%	-59.5%
Jan 20, 2022	Voliotis Dimitris79	SVP, Clinical Development	Sale+OE	30,000	$61.36	$1,840,745.23	-29.5%	-58.1%	-59.5%
Jan 18, 2022	Gallagher Cam81	Director	Sell	10,000	$62.64	$626,375.74	-0.6%	-60.2%	-60.5%
Jan 10, 2022	Bunker Kevin D.78	Chief Operating Officer	Sell	10,000	$68.41	$684,097.10	-1.3%	-55.6%	-71.3%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC